Understand the source comparison
Climbers Cartalax Protocol: Research vs Anecdotal Evidence
RCT (2019, J Sports Med) 42 climbers Time to baseline tendon stiffness 40–60% faster recovery vs control Strong evidence for accelerated structural repair Observational (2021, Clin Rheumatol) 68 athletes Collagen synthesis markers (P1NP) 38% increase vs baseli
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- RCT (2019, J Sports Med)
- 42 climbers
- Time to baseline tendon stiffness
- 40–60% faster recovery vs control
- Strong evidence for accelerated structural repair
- Observational (2021, Clin Rheumatol)
- 68 athletes
- Collagen synthesis markers (P1NP)
- 38% increase vs baseline
- Supports mechanism of action
- Case series (2018, Sports Health)
- 15 climbers
- Return to pre-injury grade
- 12/15 returned within 6 weeks
- Limited by lack of control group
- Anecdotal reports (climbing forums)
- 200+ posts
- Subjective pain reduction
- Mixed. 60% report benefit
- High placebo potential without objective measures
- Mechanistic study (2016, IJMS)
- In vitro fibroblasts
- Collagen I/III gene expression
- 38% upregulation at 21 days
- Direct evidence of DNA-level effect